Back to search results

Stereotactic Body Radiation Therapy Plus Immediate or Delayed Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy or Salvage Radiation Therapy for the Treatment of Prostate Cancer, DIVINE Trial

Abroad (travel likely)RecruitingPHASE2

Conditions

Recurrent Castration-Sensitive Prostate Carcinoma · Recurrent Prostate Cancer · Castration-resistant Prostate Cancer · Biochemically Recurrent Prostate Carcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Mayo Clinic in Arizona, Phoenix, Arizona, United States

    Contact: Study coordinator (Clinical Trials Referral Office) · mayocliniccancerstudies@mayo.edu · 855-776-0015
    Contact: Study coordinator (Cancer Center Clinical Trials) · 507-293-6386
    Contact: Principal Investigator (Jack R. Andrews, MD)

  • Mayo Clinic in Florida, Jacksonville, Florida, United States

    Contact: Study coordinator (Clinical Trials Referral Office) · mayocliniccancerstudies@mayo.edu · 855-776-0015
    Contact: Study coordinator (Cancer Center Clinical Trials) · 507-293-6386
    Contact: Principal Investigator (Adam M. Kase, MD)

  • Mayo Clinic in Rochester, Rochester, Minnesota, United States

    Contact: Study coordinator (Clinical Trials Referral Office) · mayocliniccancerstudies@mayo.edu · 855-776-0015
    Contact: Study coordinator (Cancer Center Clinical Trials) · 507-293-6386
    Contact: Principal Investigator (Jacob J. Orme, MD, PhD)
Study leads

  • Jacob J. Orme, MD, PhD

    Principal Investigator

    Mayo Clinic in Rochester

View source on ClinicalTrials.gov(opens in a new tab)